SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (1980)7/13/1998 1:53:00 PM
From: Linda Kaplan  Read Replies (2) | Respond to of 2553
 
We got our mention, we were first and they got the stock name right this time. I sold off 1/3 of the shares I bought at 5-1/4, but kept the rest, and my main position. Could it be that this stock will finally be recognized?

For those who didn't see the show, they also mentioned that the Epicel seemed to be working but they did say there are 28 companies on the stock exchange doing stuff of this kind, and they then mentioned ATIS and another one.

Guess I should have bought ATIS when I asked Henry. :-) It was nice to see GENZL spike but it will be better to see it holding -- at 14.

Linda



To: Machaon who wrote (1980)7/13/1998 9:26:00 PM
From: Exacctnt  Read Replies (1) | Respond to of 2553
 
Bob, Wouldn't you know it, I had to leave at 1 pm and never saw the story. It may have been a good call on ATIS but a lot of good it did me because I wasn't available to cash in. <g> I hope it wasn't a one day spike.

Regards,
Bob


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News